Skip to main content

Table 4 Summary of the data sets and the classification results based on 50 random sampling

From: A simpler method of preprocessing MALDI-TOF MS data for differential biomarker analysis: stem cell and melanoma cancer studies

Data set

Class

Sample type

Sample size

Total peaks

Training set (MCCV)

Blind data set

     

Train

Test

Validation

 

Melanoma

S2 v. S3

Serum

99

2560

41

14

14

30

Classification (%)

    

93.21

97.38

90.62

90.93

Cord blood

High v. Low

Plasma

158

2647

67

22

22

47

Classification (%)

    

96.45

96.73

91.18

92.34